You are here

Article info

Article menu
Download PDFPDF
Oral Presentations
Abstract session: Osteoporosis
OP0248 Inhibition of Sclerostin with Romosozumab in Postmenopausal Women with Low Bone Mineral Density: Phase 2 Trial Results

Authors

Citation

McClung MR, Grauer A, Boonen S, et al
OP0248 Inhibition of Sclerostin with Romosozumab in Postmenopausal Women with Low Bone Mineral Density: Phase 2 Trial Results
Annals of the Rheumatic Diseases 2013;72:A136-A137.

Publication history

  • First published January 23, 2014.
Online issue publication 
February 24, 2018

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© 2013, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions